Skip to content
Trial Agents

Dcl Pathology

Dcl Pathology is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

5distinct trials
2recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 5 of 5 trials · Latest update first

A Master Protocol for EG-70 in Urothelial Cancers: "A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients who are BCG Naïve or Received Incomplete BCG Treatment" BLADDER RINSE SUBSTUDY: EG-70-101 Studying the Addition of a Bladder Rinse Prior to Intravesical Administration of EG-70 in BCG-Unresponsive NMIBC Patients with CIS. IR-NMIBC SUBSTUDY: A Phase 2 Substudy of EG-70 (Detalimogene) as an Intravesical Immunoablative Treatment in Patients with Intermediate-Risk Non-Muscle Invasive Bladder Cancer (IR-NMIBC)

Sponsor Engene Inc.

Start (EU)
Latest update
Estimated end

MT-7117-A-302 Study: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria

Sponsor Tanabe Pharma America Inc.

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Dcl Pathology?

The 2026-10-09 snapshot links Dcl Pathology to 5 distinct CTIS trials. Recorded services include Laboratory services, Storing tissue samples. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Dcl Pathology?

The most frequently recorded therapeutic areas are Solid Tumor Oncology, Dermatology, Genetic and Congenital Disorders, Gynecology. Recorded phases include Phase 2, Phase 1, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Dcl Pathology conducted?

The linked trials record locations in 10 countries, including Spain, France, Italy, Germany, Belgium. These are trial locations, not confirmed office locations or countries where Dcl Pathology delivered services.

What can this page tell me about Dcl Pathology's trial experience?

Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Dcl Pathology. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Dcl Pathology LLC

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.